Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype

Human Brain Mapping

Volumn 32, Issue 10, 2011, Pages 1557-1565

  Hahn, Tim ^a   Heinzel, Sebastian ^a,b   Dresler, Thomas ^a   Plichta, Michael M ^a,c   Renner, Tobias J ^a   Markulin, Falko ^a   Jakob, Peter M ^a,d   Lesch, Klaus Peter ^a   Fallgatter, Andreas J ^a,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d Research Center Magnetic Resonance Bavaria   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Dopamine; FMRI; Genetics; Imaging; Plasticity; Reward

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; REWARD;

ADOLESCENT; ADULT; BASAL GANGLIA; BRAIN MAPPING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MINISATELLITE REPEATS; OXYGEN; PSYCHOMETRICS; REWARD; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80052682189     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21127     Document Type: Article

References (54)

1. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ (2006): Individual differences in reward drive predict neural responses to images of food. J Neurosci 26: 5160-5166.
2. Berridge KC (2007): The debate over dopamine's role in reward: The case for incentive salience. Psychopharmacology (Berl) 191: 391-431.
3. Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007): Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30: 211-219.
4. Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI (1999): Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409: 38-56.
5. Conne B, Stutz A, Vassalli JD (2000): The 3' untranslated region of messenger RNA: A molecular "hotspot" for pathology? Nat Med 6: 637-641.
6. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2008a): Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106: 617-622.
7. Dreher JC, Meyer-Lindenberg A, Kohn P, Berman KF (2008b): Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci USA 105: 15106-15111.
8. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001): Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
9. Fauchey V, Jaber M, Caron MG, Bloch B, Le Moine C (2000): Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Eur J Neurosci 12: 19-26.
10. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2007): Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14: 60-70.
11. Fowler JS, Volkow ND, Kassed CA, Chang L (2007): Imaging the addicted human brain. Sci Pract Perspect 3: 4-16.
12. Franklin TR, Lohoff FW, Wang Z, Sciortino N, Harper D, Li Y, Jens W, Cruz J, Kampman K, Ehrman R, Berrettini W, Detre JA, O'Brien CP, Childress AR (2009): DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 34: 717-728.
13. Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A (2009): Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell Signal 21: 87-94.
14. Gizer IR, Ficks C, Waldman ID (2009): Candidate gene studies of ADHD: A meta-analytic review. Hum Genet 126: 51-90.
15. Gottesman II, Gould TD (2003): The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160: 636-645.
16. Gray JA (1987). The Psychology of Fear and Stress. Cambridge: Cambridge University Press.
17. Greenwood TA, Kelsoe JR (2003): Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82: 511-520.
18. Haddley K, Vasiliou AS, Ali FR, Paredes UM, Bubb VJ, Quinn JP (2008): Molecular genetics of monoamine transporters: Relevance to brain disorders. Neurochem Res 33: 652-667.
19. Hahn T, Dresler T, Ehlis AC, Plichta MM, Heinzel S, Polak T, Lesch KP, Breuer F, Jakob PM, Fallgatter AJ (2009): Neural response to reward anticipation is modulated by Gray's impulsivity. Neuroimage 46: 1148-1153.
20. Haluk DM, Floresco SB (2009): Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 34: 2041-2052.
21. Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB (2006): Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci 26: 13213-13217.
22. Hautzinger M, Keller F, Kühner C, Bürger C. 2005. Beck Depression Inventar II (BDI 2). Bern: Huber.
23. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000): Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133-139.
24. Hernandez-Lopez S, Bargas J, Surmeier DJ, Reyes A, Galarraga E (1997): D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. J Neurosci 17: 3334-3342.
25. Horn AS (1990): Dopamine uptake: A review of progress in the last decade. Prog Neurobiol 34: 387-400.
26. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998): Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95: 4029-4034.
27. Knutson B, Cooper JC (2005): Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 18: 411-417.
28. Knutson B, Gibbs SE (2007): Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl) 191: 813-822.
29. Knutson B, Adams CM, Fong GW, Hommer D (2001): Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21: RC159.
30. Knutson B, Gibbs SE. (2007): Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl) 191: 813-822.
31. Knutson B, Rick S, Wimmer GE, Prelec D, Loewenstein G (2007): Neural predictors of purchases. Neuron 53: 147-156.
32. Krause J (2008): SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother 8: 611-625.
33. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M (2001): The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24: 553-560.
34. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002): Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. BMC Genet 114: 975-979.
35. Mill J, Asherson P, Craig I, D'Souza UM (2005): Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet. DOI: 10.1186/1471-2156-6-3.
36. Miller GM, Madras BK (2002): Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7: 44-55.
37. Mitchell JT (2009): Behavioral approach in ADHD: Testing a motivational dysfunction hypothesis. J Atten Disord 13: 609-617.
38. Plichta MM, Vasic N, Wolf RC, Lesch KP, Brummer D, Jacob C, Fallgatter AJ, Gron G (2009): Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 65: 7-14.
39. Sagvolden T, Johansen EB, Aase H, Russell VA (2005): A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28: 397-419; discussion 419-468.
40. Sava FA, Sperneac A-M (2006): Sensitivity to reward and sensitivity to punishment rating scales: A validation study on the Romanian population. Pers Indiv Differ 41: 1445-1456.
41. Scheres A, Milham MP, Knutson B, Castellanos FX (2007): Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 61: 720-724.
42. Schultz W (1998): Predictive reward signal of dopamine neurons. J Neurophysiol 80: 1-27.
43. Schultz W (2002): Getting formal with dopamine and reward. Neuron 36: 241-263.
44. Strohle A, Stoy M, Wrase J, Schwarzer S, Schlagenhauf F, Huss M, Hein J, Nedderhut A, Neumann B, Gregor A, Juckel G, Knutson B, Lehmkuhl U, Bauer M, Heinz A (2008): Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage 39: 966-972.
45. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P (2004): DARPP-32: An integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44: 269-296.
46. Torrubia R, Ávila C, Moltó J, Caseras X (2001): The sensitivity to punishment and sensitivity to reward questionnaire (SPSRQ) as a measure of Gray's anxiety and impulsivity dimensions. Pers Indiv Differ 31: 837-862.
47. Tripp G, Wickens JR (2008): Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 49: 691-704.
48. van de Giessen EM, de Win MML, Tanck MWT, van den Brink W, Baas F, Booij J (2009): Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50: 45-52.
49. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2005): Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46: 745-751.
50. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106.
51. VanNess SH, Owens MJ, Kilts CD (2005): The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet. DOI: 10.1186/1471-2156-6-55.
52. Wickens JR, Begg AJ, Arbuthnott GW (1996): Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro. Neuroscience 70: 1-5.
53. Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T, Beck A, Strohle A, Juckel G, Knutson B, Heinz A (2007): Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 35: 787-794.
54. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY (2007): A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144: 541-550.